[1] FDA. FDA Drug Safety Communication: FDA warns of serious immune system reaction with seizure and mental health medicine lamotrigine(Lamictal)[EB/OL].(2018-04-25)[2018-07-31].https://www.fda.gov/Drugs/DrugSafety/ucm605470.htm. [2] Perronnin M, Pichetti S, Sermet C.Lamotrigine-induced rash-worth a rechallenge[J]. Acta Neurologica Scandinavica, 2005, 111(3):191-194. [3] FDA. LAMICTAL label[EB/OL]. (2015-03-24)[2018-08-07]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020241s045s051lbl.pdf. [4] 何心, 张永, 徐进, 等. 77例拉莫三嗪不良反应的文献分析[J]. 中国药物警戒,2016,13(5):303-305. [5] Han S H, Hur M S, Youn H J, et al.Drug Reaction with Eosinophilia and Systemic Symptom Syndrome Induced by Lamotrigine[J]. Ann Dermatol, 2017 ,29(2):206-209. [6] Wang X Q, Lv B, Wang H F, et al.Lamotrigine induced DIHS/DRESS: Manifestations, treatment, and outcome in 57 patients[J]. Clinical Neurology & Neurosurgery, 2015, 138:1-7. [7] Mehrholz D, Urban A E, Herstowska M, et al.A retrospective study of DRESS - drug reaction with eosinophilia and systemic symptoms[J]. Psychiatria Polska, 2017, 51(6):1079-1093. [8] 方圣博, 张晓荧, 张欣, 等. 拉莫三嗪致儿童高敏综合征1例[J]. 药物流行病学杂志, 2018,27(3):213-214. [9] Barbaryan A, Iyinagoro C, Nwankwo N, et al.Ibuprofen-induced hemolytic anemia[J]. Case Rep Hematol, 2013, 2013(2013):142865. [10] 艾奇, 王欣, 乔丽津. 拉莫三嗪诱发溶血性贫血2例[J]. 中国医院药学杂志, 2016, 36(8):699-700. [11] Sarziputtini P, Panni B, Cazzola M, et al.Lamotrigine-induced lupus[J]. Lupus, 2000, 9(7):555. [12] Ravindran V.Lamotrigine-induced lupus: a case report[J]. International Journal of Rheumatic Diseases, 2011, 14(3):e47-e48. [13] 田防震, 田华. 拉莫三嗪诱发SLE 1例[J]. 中国麻风皮肤病杂志, 2006, 22(2):176-177. [14] Chang R S, Cole A J.Lamotrigine-Induced Lupus-Like Syndrome: A Case Report and Literature Review[J]. American Journal of Therapeutics, 2012, 21(3):e85. [15] Cabanillas M, Suárez-Amor O, Ramírez-Santos A, et al.Lamotrigine induced subacute cutaneous lupus erythematous[J]. Dermatology Online Journal, 2012, 18(8):12. [16] Pathak P, Mclachlan R S.Drug-induced pseudolymphoma secondary to lamotrigine[J]. Neurology, 1998, 50(5):1509. [17] Mulroy E, Walker E.Lamotrigine-related pseudolymphoma presenting as cervical lymphadenopathy[J]. Epilepsy & Behavior Case Reports, 2017, 7(C):40-41. [18] Reed Do K L, Quinn Do K, Gust A J. Cutaneous Pseudolymphoma Due to Lamotrigine: First Reported Case[J]. Hospital Pharmacy, 2015, 49(2):164-169. [19] Stephan F, Haber R, Kechichian E, et al.Lamotrigine-induced Hypersensitivity Syndrome with Histologic Features of CD30+ Lymphoma[J]. Indian J Dermatol, 2016, 61(2):235. [20] Ozisik L, Tanriover M D, Saka E.Autoimmune Limbic Encephalitis and Syndrome of Inappropriate Antidiuretic Hormone Secretion Associated with Lamotrigine-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Syndrome[J]. Internal Medicine, 2016, 55(10):1393-1396. [21] Jan-Inge Henter, AnnaCarin Horne, Maurizio Aricó, et al. HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis[J]. Pediatric Blood & Cancer, 2007, 48(2):124-131. [22] Ignaszewski M, Ignaszewski M J, Kohlitz P.Lamotrigine-Associated Hemophagocytic Lymphohistiocytosis[J]. American Journal of Therapeutics, 2017, 24(4):e493. [23] Koh M J, Tay Y K.An update on Stevens-Johnson syndrome and toxic epidermal necrolysis in children[J]. Current Opinion in Pediatrics, 2009, 21(4):505. [24] Kardaun S H, Sidoroff A, Valeyrie-Allanore L, et al.Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?[J]. British Journal of Dermatology, 2007, 156(3):609-611. [25] Shiohara T, Iijima M, Ikezawa Z, et al.The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations[J]. British Journal of Dermatology, 2010, 156(5):1083-1084. [26] 沈璐, 李馨龄, 刘巍, 等. 儿童与成人使用拉莫三嗪发生不良事件之比较-英国运用处方事件监测开展儿童上市后药物警戒之介绍[J]. 中国药物警戒, 2012, 9(10):607-614. [27] 高阳, 于爱平, 蒋玉凤, 等. HLA-B*1502等位基因与中国南方汉族癫痫患者拉莫三嗪皮肤不良反应关联性的Meta分析[J]. 中国医院药学杂志, 2016, 36(2):110-114. [28] 张婷, 肖农. 拉莫三嗪所致严重皮肤性药物不良反应的研究进展[J]. 中华神经科杂志, 2013, 46(12):850-852. [29] Magro C M, Crowson A N, Kovatich A J, et al.Drug-induced reversible lymphoid dyscrasia: a clonal lymphomatoid dermatitis of memory and activated T cells[J]. Human Pathology, 2003, 34(2):119-129. [30] TGA.Lamotrigine and serious skin reactions [EB/OL].(2010-11-30) [2018-08-01].https://www.tga.gov.au/publication-issue/medicines-safety-update-no6-2010. |